WKN: | 939391 |
ISIN: | US1598641074 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Chemie |
Weshalb die Charles River Laboratories International-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 01. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2021 | 202,00 | 328,00 | 62,38% |
2 | 2020 | 137,00 | 202,00 | 47,45% |
3 | 2019 | 94,89 | 137,00 | 44,38% |
4 | 2015 | 52,20 | 72,53 | 38,95% |
5 | 2013 | 27,52 | 38,19 | 38,77% |
6 | 2007 | 32,56 | 44,64 | 37,10% |
7 | 2014 | 38,19 | 52,20 | 36,69% |
8 | 2012 | 20,68 | 27,52 | 33,08% |
9 | 2001 | 29,20 | 38,10 | 30,48% |
10 | 2009 | 17,70 | 22,99 | 29,89% |
11 | 2017 | 71,31 | 90,45 | 26,84% |
12 | 2004 | 27,50 | 33,67 | 22,44% |
13 | 2010 | 22,99 | 26,71 | 16,18% |
14 | 2005 | 33,67 | 35,70 | 6,03% |
15 | 2018 | 90,45 | 94,89 | 4,91% |
16 | 2023 | 207,55 | 214,10 | 3,16% |
17 | 2016 | 72,53 | 71,31 | -1,68% |
18 | 2002 | 38,10 | 36,65 | -3,81% |
19 | 2006 | 35,70 | 32,56 | -8,80% |
20 | 2024 | 214,10 | 177,75 | -16,98% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 44,64 | 17,70 | -60,35% |
2 | 2022 | 328,00 | 207,55 | -36,72% |
3 | 2003 | 36,65 | 27,50 | -24,97% |
4 | 2011 | 26,71 | 20,68 | -22,58% |
5 | 2025 | 177,75 | 139,35 | -21,60% |
6 | 2024 | 214,10 | 177,75 | -16,98% |
7 | 2006 | 35,70 | 32,56 | -8,80% |
8 | 2002 | 38,10 | 36,65 | -3,81% |
9 | 2016 | 72,53 | 71,31 | -1,68% |
10 | 2023 | 207,55 | 214,10 | 3,16% |
11 | 2018 | 90,45 | 94,89 | 4,91% |
12 | 2005 | 33,67 | 35,70 | 6,03% |
13 | 2010 | 22,99 | 26,71 | 16,18% |
14 | 2004 | 27,50 | 33,67 | 22,44% |
15 | 2017 | 71,31 | 90,45 | 26,84% |
16 | 2009 | 17,70 | 22,99 | 29,89% |
17 | 2001 | 29,20 | 38,10 | 30,48% |
18 | 2012 | 20,68 | 27,52 | 33,08% |
19 | 2014 | 38,19 | 52,20 | 36,69% |
20 | 2007 | 32,56 | 44,64 | 37,10% |